CD8A and esophageal cancer: Previous research has shown that neoadjuvant chemotherapy, whether administered alone or in combination with neoadjuvant radiotherapy, resulted in an augmentation of CD8 + T effector cell infiltration and a reduction in Treg cell populations in esophageal cancer patients [30, 31].